Working together to deliver cell and gene therapies for people impacted by serious diseases Learn More Our inspiration Learn More Pipeline Explore R&D pz-cel (prademagene zamikeracel) BLA submitted for investigational autologous, COL7A1 gene-corrected epidermal sheets for RDEB. Learn More ABO-50X Exploring the potential of ABO-50X for the treatment of genetic eye disorders. Learn More Latest News Jul 11, 2024 Abeona Therapeutics and Beacon Therapeutics Announce Non-Exclusive Agreement for Beacon to Evaluate Therapeutic Potential of Abeona's Patented AAV204 Capsid for Select Ophthalmology Indications View Press Release Jul 8, 2024 Abeona Therapeutics to Present at the Stifel Virtual Cell Therapy Forum View Press Release Jun 3, 2024 Abeona Therapeutics Announces New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) View Press Release View All Manufacturing at The Elisa Linton Center for Rare Disease Therapies Learn More